Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection.

COVID-19 T cell exhaustion/senescence convalescents full spectral cytometry immune system inflammation resolution long COVID post-acute COVID-syndrome (PACS)

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 28 02 2022
accepted: 22 04 2022
entrez: 27 6 2022
pubmed: 28 6 2022
medline: 29 6 2022
Statut: epublish

Résumé

Several COVID-19 convalescents suffer from the post-acute COVID-syndrome (PACS)/long COVID, with symptoms that include fatigue, dyspnea, pulmonary fibrosis, cognitive dysfunctions or even stroke. Given the scale of the worldwide infections, the long-term recovery and the integrative health-care in the nearest future, it is critical to understand the cellular and molecular mechanisms as well as possible predictors of the longitudinal post-COVID-19 responses in convalescent individuals. The immune system and T cell alterations are proposed as drivers of post-acute COVID syndrome. However, despite the number of studies on COVID-19, many of them addressed only the severe convalescents or the short-term responses. Here, we performed longitudinal studies of mild, moderate and severe COVID-19-convalescent patients, at two time points (3 and 6 months from the infection), to assess the dynamics of T cells immune landscape, integrated with patients-reported symptoms. We show that alterations among T cell subsets exhibit different, severity- and time-dependent dynamics, that in severe convalescents result in a polarization towards an exhausted/senescent state of CD4+ and CD8+ T cells and perturbances in CD4+ Tregs. In particular, CD8+ T cells exhibit a high proportion of CD57+ terminal effector cells, together with significant decrease of naïve cell population, augmented granzyme B and IFN-γ production and unresolved inflammation 6 months after infection. Mild convalescents showed increased naïve, and decreased central memory and effector memory CD4+ Treg subsets. Patients from all severity groups can be predisposed to the long COVID symptoms, and fatigue and cognitive dysfunctions are not necessarily related to exhausted/senescent state and T cell dysfunctions, as well as unresolved inflammation that was found only in severe convalescents. In conclusion, the post-COVID-19 functional remodeling of T cells could be seen as a two-step process, leading to distinct convalescent immune states at 6 months after infection. Our data imply that attenuation of the functional polarization together with blocking granzyme B and IFN-γ in CD8+ cells might influence post-COVID alterations in severe convalescents. However, either the search for long COVID predictors or any treatment to prevent PACS and further complications is mandatory in all patients with SARS-CoV-2 infection, and not only in those suffering from severe COVID-19.

Identifiants

pubmed: 35757700
doi: 10.3389/fimmu.2022.886431
pmc: PMC9226563
doi:

Substances chimiques

Granzymes EC 3.4.21.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

886431

Informations de copyright

Copyright © 2022 Wiech, Chroscicki, Swatler, Stepnik, De Biasi, Hampel, Brewinska-Olchowik, Maliszewska, Sklinda, Durlik, Wierzba, Cossarizza and Piwocka.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Brain. 2021 Dec 31;144(12):3576-3588
pubmed: 34398188
Nat Rev Immunol. 2021 Apr;21(4):245-256
pubmed: 33723416
J Immunol. 2002 Jun 1;168(11):5538-50
pubmed: 12023349
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
Eur J Immunol. 2021 Dec;51(12):2708-3145
pubmed: 34910301
Front Immunol. 2020 Oct 14;11:580237
pubmed: 33154753
Viruses. 2021 Nov 26;13(12):
pubmed: 34960645
Cell. 2021 Feb 18;184(4):861-880
pubmed: 33497610
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Immunology. 2011 Sep;134(1):17-32
pubmed: 21711350
Nat Med. 2021 Apr;27(4):626-631
pubmed: 33692530
Nat Commun. 2021 Jan 12;12(1):302
pubmed: 33436591
Vaccines (Basel). 2021 May 12;9(5):
pubmed: 34066007
Trends Pharmacol Sci. 2015 Nov;36(11):737-755
pubmed: 26478210
Cell. 2020 Oct 1;183(1):158-168.e14
pubmed: 32979941
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Cell. 2021 Apr 1;184(7):1671-1692
pubmed: 33743212
Proc Natl Acad Sci U S A. 2021 Sep 14;118(37):
pubmed: 34433692
Front Microbiol. 2021 Jun 23;12:698169
pubmed: 34248921
Nat Commun. 2020 Jul 6;11(1):3434
pubmed: 32632085
Aging Dis. 2021 Oct 1;12(7):1545-1553
pubmed: 34631206
Arch Med Res. 2021 Aug;52(6):575-581
pubmed: 33962805
J Intensive Care. 2021 Dec 20;9(1):76
pubmed: 34930468
Cell Rep Med. 2021 Jul 20;2(7):100354
pubmed: 34250512
Pathogens. 2021 Oct 30;10(11):
pubmed: 34832564
Front Immunol. 2021 Sep 29;12:748097
pubmed: 34659245
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
Immunity. 2020 Dec 15;53(6):1296-1314.e9
pubmed: 33296687
AIDS. 2020 Dec 1;34(15):2169-2185
pubmed: 32910071
Front Immunol. 2021 Oct 21;12:769059
pubmed: 34745145
JCI Insight. 2021 Dec 22;6(24):
pubmed: 34784300
Trends Immunol. 2009 Jul;30(7):306-12
pubmed: 19540809
J Invest Dermatol. 2021 Mar;141(3):575-585
pubmed: 32738245
Nat Commun. 2021 Jul 29;12(1):4677
pubmed: 34326336
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
J Virol. 2020 Dec 23;:
pubmed: 33361429
EMBO Mol Med. 2020 Dec 7;12(12):e13001
pubmed: 33078545
Cells. 2020 Dec 05;9(12):
pubmed: 33291439
Cell. 2022 Mar 3;185(5):881-895.e20
pubmed: 35216672
Cells. 2021 Jun 19;10(6):
pubmed: 34205262
J Clin Invest. 2020 Dec 1;130(12):6588-6599
pubmed: 32841212
J Clin Invest. 2021 Jan 4;131(1):
pubmed: 33119547
Front Immunol. 2016 Apr 26;7:160
pubmed: 27199985
Nat Immunol. 2022 Feb;23(2):210-216
pubmed: 35027728
Nat Commun. 2021 May 10;12(1):2593
pubmed: 33972535
Eur J Immunol. 2020 Sep;50(9):1283-1294
pubmed: 32910469
Nat Biotechnol. 2020 Aug;38(8):970-979
pubmed: 32591762
Lancet Neurol. 2020 Sep;19(9):767-783
pubmed: 32622375
Glob Adv Health Med. 2021 Nov 16;10:21649561211056597
pubmed: 34820152
J Exp Med. 2021 Feb 1;218(2):
pubmed: 33119033
Eur J Immunol. 2016 Oct;46(10):2286-2301
pubmed: 27595500
J Neurol. 2021 Sep;268(9):3059-3071
pubmed: 33486564
Cell Rep. 2021 Aug 10;36(6):109518
pubmed: 34358460
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
Int J Med Sci. 2018 Apr 3;15(7):666-673
pubmed: 29910670
BMC Med. 2022 Jan 14;20(1):26
pubmed: 35027067
Allergy. 2021 Mar;76(3):751-765
pubmed: 33128792
J Clin Immunol. 2021 Oct;41(7):1490-1501
pubmed: 34273064
Nature. 2021 Jun;594(7862):168-170
pubmed: 34108700
Front Immunol. 2020 Dec 03;11:611004
pubmed: 33343585

Auteurs

Milena Wiech (M)

Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.

Piotr Chroscicki (P)

Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.

Julian Swatler (J)

Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.

Dawid Stepnik (D)

Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.

Sara De Biasi (S)

Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia School of Medicine, Modena, Italy.

Michal Hampel (M)

Department of Gastroenterological Surgery and Transplantology, Central Clinical Hospital of the Ministry of Interior, Warsaw, Poland.

Marta Brewinska-Olchowik (M)

Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.

Anna Maliszewska (A)

Department of Gastroenterological Surgery and Transplantology, Central Clinical Hospital of the Ministry of Interior, Warsaw, Poland.

Katarzyna Sklinda (K)

Department of Radiology, Centre of Postgraduate Medical Education, Warsaw, Poland.

Marek Durlik (M)

Department of Gastroenterological Surgery and Transplantology, Central Clinical Hospital of the Ministry of Interior, Warsaw, Poland.
Departament of Gastroenterological Surgery and Transplantology, Centre of Postgraduate Medical Education, Warsaw, Poland.

Waldemar Wierzba (W)

Central Clinical Hospital of the Ministry of Interior, Warsaw, Poland.
University of Humanities and Economics, Lodz, Poland.

Andrea Cossarizza (A)

Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia School of Medicine, Modena, Italy.
National Institute for Cardiovascular Research, Bologna, Italy.

Katarzyna Piwocka (K)

Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH